13N-Ammonia PET Assessment of Lower Extremity Perfusion in Peripheral Vascular Disease

13N-Ammonia PET Assessment of Lower Extremity Perfusion in Peripheral Vascular Disease - 13N-Ammonia PET Assessment of Lower Extremity Perfusion in Peripheral Vascular Disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023337

Enrollment

Registered

2016-07-30

Start date

2012-03-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Vascular Disease

Interventions

Ammonia PET/CT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)patients undergoing ammmonia PET/CT before and after treatment 2)patients with peripheral arterial disease and volunteers agreeing with this study after informed concent

Exclusion criteria

Exclusion criteria: 1. patients judged not eligible in this study 2. patients who have a serious underlying disease , a person who liver dysfunction , renal failure , or metabolic disorders are expected , performance status 4 . 3. patients with a history of hypersensitivity to ammonia 4. possibility of pregnancy. 5. regarded as unsuitable by investigator.

Design outcomes

Primary

Measure	Time frame
Ammonia PET was performed before and after medical treatment for patients with peripheral arterial occlusive disease , examine subjective symptoms , SPP, the correlation between ABI, TcPO2.	—

Countries

Japan

Contacts

Public Contactyokomiyata

National center for global health and medicine Nuclear medicine

dyokomiyata@hospk.ncgm.go.jp03-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026